Results 71 to 80 of about 175,299 (292)
Managing menopausal symptoms and associated clinical issues in breast cancer survivors [PDF]
Objective: Review evidence to guide management of menopausal signs and symptoms in women after breast cancer and make recommendations accordingly. Evidence: Randomized controlled clinical trials, observational studies, evidence-based guidelines, and
Davis, Susan R.+5 more
core +1 more source
Pseudocyesis in peri- and postmenopausal women [PDF]
Abstract Pseudocyesis or delusion of pregnancy is a rare psychopathological syndrome described in humans and higher mammals. We describe and discuss two cases of this rare syndrome in a 46-year perimenopausal and a 59-year old postmenopausal woman.
openaire +3 more sources
Diabetes mellitus (DM) and chronic kidney disease (CKD) impact bone health in the elderly. A study of 571 patients revealed higher BMD in DM, with HbA1c positively linked to BMD. CKD nullified this association without worsening T‐scores. Tailored interventions—BMD monitoring, glycemic control, and fracture prevention—are essential for risk mitigation ...
Debajyoti Roy+6 more
wiley +1 more source
Adherence to adjuvant therapy in post-menopausal breast cancer patients: A review [PDF]
This is the post-print version of the Article. The official published version can be accessed from the link below - Copyright @ 2012 John Wiley & Sons, IncThis review aimed to address the concept of adherence to adjuvant therapy in post-menopausal women.
Banning, M
core +1 more source
ABSTRACT Women with the FMR1 premutation (FXpm) are at heightened genetic vulnerability for depression, with risk compounded by the stressors of parenting a disabled child. Although risk factors persist as FXpm women age, depression in FXpm mothers during midlife and old age is poorly characterized. This study used an accelerated longitudinal design to
Jessica Klusek+8 more
wiley +1 more source
Recommendations for raloxifene use in daily clinical practice in the Swiss setting [PDF]
Background/aim: Raloxifene is the first selective estrogen receptor modulator that has been approved for the treatment and prevention of osteoporosis in postmenopausal women in Europe and in the US. Although raloxifene reduces the risk of invasive breast
Birkhäuser, M.+9 more
core
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline
Objective To investigate how sex and age at menopause influence the interplay between Alzheimer's disease (AD) and Lewy body disease (LBD) neuropathologies, and their associations with cognitive decline. Methods We analyzed data from: (1) three Rush Alzheimer's Disease Center cohorts (i.e., the Religious Orders Study, Rush Memory and Aging Project, and
Madeline Wood Alexander+17 more
wiley +1 more source
Background Global studies exploring the relationship between parity and chronic kidney disease (CKD) are scarce. Furthermore, no study has examined the relationship between parity and CKD in Japan.
Hongxin Wang+14 more
doaj +1 more source
Diet and bone mineral density study in postmenopausal women from the TwinsUK registry shows a negative association with a traditional English dietary pattern and a positive association with wine [PDF]
Background: The effect of diet on bone mineral density (BMD) remains controversial, mainly because of difficulties in isolating dietary factors from the confounding influences of age, lifestyle, and genetic factors.
Aedín Cassidy+24 more
core +1 more source
Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley +1 more source